POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Clinical trials for POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS trials appear
Sign up with your email to follow new studies for POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on childhood arthritis and autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing a new treatment using specially engineered immune cells (CAR-T cells) in 11 children with severe rheumatic diseases like juvenile dermatomyositis, arthritis, and scleroderma that haven't responded to standard therapies. The goal is to see if thes…
Matched conditions: POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated May 17, 2026 04:11 UTC
-
Real-World check: arthritis drug xeljanz under review for kids in korea
Disease control Recruiting nowThis study monitors the safety and effectiveness of Xeljanz in children aged 2 to 17 with active juvenile idiopathic arthritis or juvenile psoriatic arthritis. It is a post-marketing surveillance required by Korean regulators, following children for up to 44 weeks in routine care…
Matched conditions: POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Sponsor: Pfizer • Aim: Disease control
Last updated May 15, 2026 11:54 UTC